Adjuvant interferon treatment for melanoma

被引：25

作者：

Agarwala, SS ^{[1
]}

Kirkwood, JM ^{[1
]}

机构：

[1] Univ Pittsburgh, Ctr Hlth, Pittsburgh, PA USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1998年 / 12卷 / 04期

关键词：

D O I：

10.1016/S0889-8588(05)70025-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This article summarizes recent and ongoing efforts in the area of adjuvant interferon treatment for cutaneous melanoma. Interferon therapy targets the immune system in an attempt to cure high-risk melanoma. More than a decade of interferon research has culminated in the successful application of interferon-alpha-2b in melanoma, with significantly prolonged survival in patients at high risk for recurrence after surgical resection.

引用

页码：823 / +

页数：12

共 24 条

[11] Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from eastern cooperative oncology group 1684
Hillner, BE
Kirkwood, JM
Atkins, MB
Johnson, ER
Smith, TJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2351 - 2358
[12] VIRUS INTERFERENCE .1. THE INTERFERON
ISAACS, A
LINDENMANN, J
[J]. PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1957, 147 (927): : 258 - 267
[13] JONES PC, 1981, J NATL CANCER I, V66, P249
[14] Kirkwood JM, 1997, ADJ THER CANC, V8, P251
[15] Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684
Kirkwood, JM
Strawderman, MH
Ernstoff, MS
Smith, TJ
Borden, EC
Blum, RH
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 7 - 17
[16] Cancer statistics, 1998
Landis, SH
Murray, T
Bolden, S
Wingo, PA
[J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1998, 48 (01) : 6 - +
[17] IMPROVED SURVIVAL IN STAGE-III MELANOMA PATIENTS WITH GM2 ANTIBODIES - A RANDOMIZED TRIAL OF ADJUVANT VACCINATION WITH GM2 GANGLIOSIDE
LIVINGSTON, PO
WONG, GYC
ADLURI, S
TAO, Y
PADAVAN, M
PARENTE, R
HANLON, C
CALVES, MJ
HELLING, F
RITTER, G
OETTGEN, HF
LLOYD, JO
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (05) : 1036 - 1044
[18] LIVINGSTON PO, 1997, MOL DIAGNOSIS TREATM
[19] RECOMBINANT HUMAN INTERFERON-GAMMA - ADVERSE-EFFECTS IN HIGH-RISK STAGE-I AND STAGE-II CUTANEOUS MALIGNANT-MELANOMA
MEYSKENS, FL
KOPECKY, K
SAMSON, M
HERSH, E
MACDONALD, J
JAFFE, H
CROWLEY, J
COLTMAN, C
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (12) : 1071 - 1071
[20] RANDOMIZED TRIAL OF ADJUVANT HUMAN INTERFERON-GAMMA VERSUS OBSERVATION IN HIGH-RISK CUTANEOUS MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
MEYSKENS, FL
KOPECKY, KJ
TAYLOR, CW
NOYES, RD
TUTHILL, RJ
HERSH, EM
FEUN, LG
DOROSHOW, JH
FLAHERTY, LE
SONDAK, VK
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (22) : 1710 - 1713

← 1 2 3 →